Affordable Access

Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon.

Authors
Type
Published Article
Journal
Techniques in urology
Publication Date
Volume
6
Issue
3
Pages
221–222
Identifiers
PMID: 10963494
Source
Medline

Abstract

Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F